`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`J KYLE BASS and ERICH SPANGENBERG
`
`Petitioner
`
`v.
`
`FRESENIUS KABI USA, LLC.
`
`Patent Owner
`
`Case No. IPR2016-00254
`
`Patent No. 8,476,010 B2
`
`PATENT OWNER’S MOTION FOR PRO HAC VICE ADMISSION OF
`DARYL L. WIESEN UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2016-00254
`
`I.
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED
`
`Pursuant to the Board’s “Notice of Filing Date Accorded to Petition and
`
`Time for Filing Patent Owner Preliminary Response,” dated December 10, 2015
`
`(Paper No. 3), authorizing the parties to file motions for pro hac vice admission
`
`under 37 C.F.R. § 42.10(c), Patent Owner Fresenius Kabi USA, LLC. respectfully
`
`requests that the Board allow Daryl L. Wiesen to appear pro hac vice on its behalf
`
`in this proceeding. Petitioner consents to this motion.
`
`II. REASONS THE REQUESTED RELIEF SHOULD BE GRANTED
`As set forth in the Statement of Material Facts below, and as required by 37
`
`C.F.R. § 42.10(c), Patent Owner has demonstrated good cause to admit Mr.
`
`Wiesen pro hac vice in this proceeding. In particular, Patent Owner’s lead counsel
`
`is a registered practitioner, and Mr. Wiesen is an experienced litigating attorney
`
`having an established familiarity with the subject matter at issue in this proceeding.
`
`Furthermore, this motion is being filed more than twenty one days after
`
`service of the petition; includes a statement of facts showing good cause for the
`
`Board to recognize Mr. Wiesen pro hac vice; and is being filed concurrently with
`
`Exhibit 2033, the Declaration of Daryl L. Wiesen in Support of Patent Owner’s
`
`Motion for Pro Hac Vice Admission of Daryl L. Wiesen (“Wiesen Decl.”), all in
`
`accordance with the “Order Authorizing Motion for Pro Hac Vice Admission” in
`
`
`
`
`1
`
`
`
`Case No. IPR2016-00254
`
`Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper 7 at 3 (P.T.A.B.
`
`Oct. 15, 2013).
`
`III. STATEMENT OF MATERIAL FACTS
`1. 37 C.F.R. § 42.10(c) provides that “[t]he Board may recognize counsel pro
`
`hac vice during a proceeding upon a showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner and to any other
`
`conditions as the Board may impose. For example, where the lead counsel is a
`
`registered practitioner, a motion to appear pro hac vice by counsel who is not a
`
`registered practitioner may be granted upon showing that counsel is an
`
`experienced litigating attorney and has an established familiarity with the subject
`
`matter at issue in the proceeding.”
`
`2. Eleanor M. Yost, lead counsel for Patent Owner Fresenius Kabi USA,
`
`LLC.in this proceeding, is a registered practitioner holding Registration No.
`
`58,013.
`
`3. As set forth in the Wiesen Decl., Mr. Wiesen is an experienced litigating
`
`attorney. Specifically, Mr. Wiesen has nearly 20 years of experience
`
`representing clients in patent litigations, primarily in the chemical arts, in United
`
`States district courts and the Court of Appeals for the Federal Circuit. (Wiesen
`
`Decl., ¶¶ 2-3). Mr. Wiesen also has over five yearsof experience litigating cases
`
`
`
`
`2
`
`
`
`Case No. IPR2016-00254
`
`on behalf of the Patent Owner, both generally and in litigations related Diprivan.
`
`(Wiesen Decl., ¶¶ 5-7).
`
`4. Mr. Wiesen also has an established familiarity with the precise subject
`
`matter at issue in this proceeding. Patent Owner was recently involved in district
`
`court litigation involving U.S. Patent No. 8,476,010 B2 (“the ’010 patent”), the
`
`patent at issue in this proceeding, in Fresenius Kabi USA, LLC.. v. Watson
`
`Laboratories Inc. et al., Civil Action No. 1:14-cv-00161RGA (D.Del.), Fresenius
`
`Kabi USA, LLC. v. Dr. Reddy’s Laboratories Ltd. et al., Civil Action No. 1:14-
`
`cv-00160-RGA (D.Del.), Fresenius Kabi USA, LLC. v. Emcure Pharmaceuticals
`
`Inc. et al., Civil Action No. 14-cv-5584 (DNJ), Fresenius Kabi USA, LLC.. v.
`
`Mylan Laboratories. et al., Civil Action No. 1:14-cv-1438-RGA (D.Del.),
`
`Fresenius Kabi USA, LLC. v. Claris Life Sciences Ltd. et al., Civil Action No.
`
`1:14-cv-07953 (DNJ) and Fresenius Kabi USA, LLC v. B. Braun Medical Inc.
`
`Civil Action No. 1:16-cv-00250 (D.Del.). Mr. Wiesen was also involved in
`
`district court litigation involving other patents concerning Diprivan in Fresenius
`
`Kabi USA LLC v. Dr. Reddy's Laboratories Ltd. et al., Civil Action No. 1:13-cv-
`
`00925-RGA (D.Del.) Mr. Wiesen was litigation counsel for Fresenius Kabi USA
`
`LLC. in these litigations. In the course of this representation, he has developed a
`
`strong familiarity with the ’010 patent, its prosecution history, the general subject
`
`matter to which the ’010 patent is directed, and the prior art references relied
`
`
`
`
`3
`
`
`
`Case No. IPR2016-00254
`
`upon by Petitioner in support of its invalidity grounds in this proceeding.
`
`(Wiesen Decl., ¶ 8). Additionally, Mr. Wiesen has thoroughly reviewed the
`
`Petition and accompanying Exhibits submitted in this proceeding. (Id.).
`
`5. Mr. Wiesen has attested to the each of the requirements set forth in
`
`paragraph 2(b)(i)-(viii) of the “Order Authorizing Motion for Pro Hac Vice
`
`Admission” in Case IPR2013-00639, Paper 7 at 3. (Wiesen Decl., ¶¶ 3, 4, 6-8, 9-
`
`13).
`
`IV. CONCLUSION
`In view of the foregoing, Patent Owner respectfully submits that the
`
`requirements of 37 C.F.R. § 42.10(c) have been satisfied, and requests an Order
`
`permitting Daryl L. Wiesen to appear pro hac vice on its behalf in this proceeding.
`
`
`
`Dated: August 4, 2016
`
`Respectfully submitted,
`
`
`
`/ Eleanor M. Yost /
`(Reg. No. 58,013)
`901 New York Avenue NW
`Washington, DC 20001
`Tel: 202-346-4000
`Fax: 202-346-4444
`eyost@goodwinprocter.com
`
`Counsel for Patent Owner Fresenius Kabi
`USA, LLC.
`
`
`
`
`4
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that PATENT OWNER’S MOTION FOR
`
`PRO HAC VICE ADMISSION OF DARYL L. WIESEN UNDER 37 C.F.R. §
`
`42.10(c), was served electronically via e-mail on August 4, 2016 on the following:
`
`Dr. Gregory J. Gonsalves
`
`gonsalves@gonsalveslawfirm.com
`
`Christopher Casieri
`
`chris@miplaw.com
`
`
`
`Dated: August 4, 2016
`
`/Eleanor M. Yost/
`
`
`
`
`
`Eleanor M. Yost